A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients
NCT00002198 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to see how the body processes 1592U89 and ethanol (pure grain alcohol) when they are given together.
Conditions
- HIV Infections
Interventions
- DRUG
-
Abacavir sulfate
Sponsors & Collaborators
-
Glaxo Wellcome
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
NCT00009061 ·Status: UNKNOWN ·Phase: PHASE3
-
Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects
NCT00765271 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Pharmacokinetics in HIV-infected Women
NCT00433979 ·Status: COMPLETED
-
Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects
NCT00320307 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
NCT00038636 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants
NCT00833482 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
NCT00002223 ·Status: COMPLETED ·Phase: NA
-
GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir
NCT00883935 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers
NCT03894124 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir
NCT00000898 ·Status: COMPLETED ·Phase: NA
-
Blood Levels of Abacavir in HIV Infected Adolescents
NCT00087945 ·Status: COMPLETED ·Phase: NA
-
A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults
NCT02990325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
NCT00435929 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
NCT00915655 ·Status: COMPLETED ·Phase: PHASE2
-
Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir
NCT00120393 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of Atazanavir 300 mg Capsule
NCT00393328 ·Status: COMPLETED ·Phase: PHASE1
-
A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
NCT02289495 ·Status: TERMINATED ·Phase: PHASE1
-
To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir
NCT00335192 ·Status: COMPLETED ·Phase: PHASE4
-
A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat
NCT02565888 ·Status: COMPLETED ·Phase: PHASE1
-
HLA-B*5701 And Hypersensitivity To Abacavir
NCT00373945 ·Status: COMPLETED
-
Drug Interaction Study
NCT00646776 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interactions Among Anti-HIV Agents
NCT00001766 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs
NCT00920088 ·Status: COMPLETED ·Phase: PHASE1
-
Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents
NCT00011479 ·Status: COMPLETED ·Phase: PHASE1
-
Islatravir and Methadone Pharmacokinetics (MK-8591-029)
NCT04568603 ·Status: COMPLETED ·Phase: PHASE1